Cargando…
Prostate Cancer Dormancy and Reactivation in Bone Marrow
Prostate cancer has a variable clinical course, ranging from curable local disease to lethal metastatic spread. Eradicating metastatic cells is a unique challenge that is rarely met with the available therapies. Thus, targeting prostate cancer cells in earlier disease states is a crucial window of o...
Autores principales: | Singh, Deepak K., Patel, Vaibhav G., Oh, William K., Aguirre-Ghiso, Julio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234151/ https://www.ncbi.nlm.nih.gov/pubmed/34208521 http://dx.doi.org/10.3390/jcm10122648 |
Ejemplares similares
-
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
por: Yumoto, Kenji, et al.
Publicado: (2016) -
Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling
por: Ghiso, Julio A. Aguirre, et al.
Publicado: (1999) -
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012) -
Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow
por: Wieder, Robert
Publicado: (2022) -
Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow
por: Jung, Younghun, et al.
Publicado: (2020)